Sym-005

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSym-005

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSymphogen A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSymphogen A/S

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A